Your browser doesn't support javascript.
loading
Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer.
Akhoundova, Dilara; Pietge, Heike; Hussung, Saskia; Kiessling, Michael; Britschgi, Christian; Zoche, Martin; Rechsteiner, Markus; Weber, Achim; Fritsch, Ralph M.
Afiliación
  • Akhoundova D; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Pietge H; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Hussung S; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Kiessling M; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Britschgi C; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Zoche M; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
  • Rechsteiner M; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
  • Weber A; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
  • Fritsch RM; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
JCO Precis Oncol ; 5: 1082-1087, 2021 11.
Article en En | MEDLINE | ID: mdl-34994629
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf Límite: Adult / Humans / Male Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf Límite: Adult / Humans / Male Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza